Results

Bristol-Myers Squibb Company

04/16/2021 | Press release | Distributed by Public on 04/16/2021 11:17

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal[...]